SOT-201

N/A

Report date: 2024/05/13 14:30:22

Base Information

Drug NameSOT-201
Drug Alias NameSOT-201SO C108SO-C108
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-15 receptors agonistsInterleukin-2 receptor agonistsProgrammed cell death protein 1 blockers
TargetsInterleukin-15 receptorsInterleukin-2 receptorProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSotio
China Registration ClassN/A

Develop Information

Active CompaniesSotio Biotech AG
Inactive CompaniesSotio
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A